Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes

D. R. Matthews; G. Fulcher; V. Perkovic; D. de Zeeuw; K. W. Mahaffey; J. Rosenstock; M. Davies; G. Capuano; M. Desai; W. Shaw; F. Vercruysse; G. Meininger; B. Neal

Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes

D. R. Matthews, G. Fulcher, V. Perkovic, D. de Zeeuw, K. W. Mahaffey, J. Rosenstock, M. Davies, G. Capuano, M. Desai, W. Shaw, F. Vercruysse, G. Meininger, B. Neal

Groningen Kidney Center (GKC)

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S314-S315
Number of pages	2
Journal	Diabetologia
Volume	55
Publication status	Published - Oct-2012

Handle.net

Persistent link

Cite this

Matthews, D. R., Fulcher, G., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Rosenstock, J., Davies, M., Capuano, G., Desai, M., Shaw, W., Vercruysse, F., Meininger, G., & Neal, B. (2012). Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes. Diabetologia, 55, S314-S315.

@article{4d81329c637c47e68f53bd6e929d4652,

title = "Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes",

author = "Matthews, {D. R.} and G. Fulcher and V. Perkovic and {de Zeeuw}, D. and Mahaffey, {K. W.} and J. Rosenstock and M. Davies and G. Capuano and M. Desai and W. Shaw and F. Vercruysse and G. Meininger and B. Neal",

year = "2012",

month = oct,

language = "English",

volume = "55",

pages = "S314--S315",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

}

Matthews, DR, Fulcher, G, Perkovic, V, de Zeeuw, D, Mahaffey, KW, Rosenstock, J, Davies, M, Capuano, G, Desai, M, Shaw, W, Vercruysse, F, Meininger, G & Neal, B 2012, 'Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes', Diabetologia, vol. 55, pp. S314-S315.

TY - JOUR

T1 - Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes

AU - Matthews, D. R.

AU - Fulcher, G.

AU - Perkovic, V.

AU - de Zeeuw, D.

AU - Mahaffey, K. W.

AU - Rosenstock, J.

AU - Davies, M.

AU - Capuano, G.

AU - Desai, M.

AU - Shaw, W.

AU - Vercruysse, F.

AU - Meininger, G.

AU - Neal, B.

PY - 2012/10

Y1 - 2012/10

M3 - Meeting Abstract

SN - 0012-186X

VL - 55

SP - S314-S315

JO - Diabetologia

JF - Diabetologia

ER -